Sol-Guard Safety Pull Button Collection Set; Sol-Guard XtraThin Safety Pull-Button Blood Collection Set
Sol-Millennium Medical, Inc. · Decision date Oct 21, 2026
What did the FDA decide?
Sol-Millennium Medical, Inc. (Chicago, IL) received a substantially equivalent (SESE) decision for the Sol-Guard™ Safety Pull Button Collection Set and Sol-Guard™ XtraThin Safety Pull-Button Blood Collection Set under 510(k) K260857. The FDA recorded the decision on 2026-10-21, with the application received 03/16/2026. The device falls under regulation 862.1675, classification product code JKA with subsequent product code FPA, in the Clinical Chemistry specialty, reviewed by the General Hospital panel. SESE denotes 510(k) clearance, not PMA approval.
The public record identifies the applicant and correspondent as Sol-Millennium Medical, Inc., with Mike Xie listed as contact for both. The summary is typed Special; the page states the review was not by a third party, the submission is not a combination product, and no Predetermined Change Control Plan was authorized. The record does not describe the specific components, design changes or performance data behind the clearance, so those details remain unknown from this source.
No clinical or comparative claims should be drawn from the decision alone; the underlying summary documentation was not available in the retrieved excerpt.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Oct 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260857
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Sol-Millennium Medical, Inc.
- Product code
- JKA
- Decision code
- SESE
- Decision date
- Oct 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tubes, Vials, Systems, Serum Separators, Blood Collection.
- Applicant
- Sol-Millennium Medical, Inc.
- Product code
- JKA
- FDA device class
- 2
FDA decision timeline
K260857 received
Application receipt date recorded by FDA.
K260857 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JKA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| CMT Health PTE., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Becton Dickinson and Company | 510(k) clearance | Oct 16, 2026 | FDA | |
| CMT Health PTE., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sol-Millennium Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Chicago, IL
Sources and methodology
- Original FDA record: K260857
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

